ANI Pharmaceuticals
ANIPANI Pharmaceuticals is a diversified biopharmaceutical company focused on developing, manufacturing, and commercializing therapeutics for rare diseases, brands, and generic markets.
Earnings
Next report
Nov 6, 2026 (in 2 months)Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
Profile
ANI Pharmaceuticals is a diversified biopharmaceutical company focused on developing, manufacturing, and commercializing therapeutics for rare diseases, brands, and generic markets. The company leverages its internal R&D and strategic acquisitions to deliver high-quality medicines to patients with unmet medical needs. Its value proposition is built on a robust manufacturing infrastructure and a growing portfolio of specialized pharmaceutical products.
ANI Pharmaceuticals maintains a competitive edge through its specialized manufacturing facilities and a diversified portfolio that balances high-growth rare disease assets with a stable, high-volume generics business.
FAQ
- What is ANI Pharmaceuticals's market cap?
- ANI Pharmaceuticals (ANIP) has a market capitalization of $1.7B and trades on NASDAQ.
- What is ANI Pharmaceuticals's revenue and profitability?
- ANI Pharmaceuticals generated $978.4M in trailing twelve-month revenue with net income of $108.3M, representing a net margin of 11.1%. Gross margin stands at 60.4%, with free cash flow of $173.0M. The latest reported period is Q2 2026.
- Who are ANI Pharmaceuticals's competitors?
- ANI Pharmaceuticals's key competitors include Amneal Pharmaceuticals, Inc., Viatris Inc., Alnylam Pharmaceuticals, Inc., and others. These companies compete in similar markets and product categories.
- Who does ANI Pharmaceuticals partner with?
- ANI Pharmaceuticals's notable partners include JPMorgan Chase Bank, N.A., Truist Bank.
- What subsidiaries does ANI Pharmaceuticals have?
- ANI Pharmaceuticals's subsidiaries include Alimera Sciences, Inc..
- Where is ANI Pharmaceuticals headquartered?
- ANI Pharmaceuticals is headquartered in United States of America and employs approximately 642 people. It has been publicly traded since 1999.
